Monday, July 21, 2014
An article, co-authored by Regents' Professor Gary Marchant, Faculty Director of the College of Law's Center for Law, Science & Innovation, was featured in Genetic Engineering & Biotechnology News.
The article titled, Will Liability Drive Personalized Medicine? explores the rapid growth of genetic data and technologies and how it might present additional liability risks to healthcare providers.
In the article the authors assert that practitioners should exercise extra care in handling genetic information and carefully document each genetics test that is used as well as the reasoning for why other tests were not used.
Marchant co-authored the article with Rachel Lindor, M.D., J.D., a resident at the Mayo Clinic in Rochester, MN.
Read the entire article here.
Marchant's research interests include the use of genetic information in environmental regulator, risk and the precautionary principle, legal aspects of personalized medicine, and regulation of emerging technologies such as nanotechnology, neuroscience and biotechnology. He teaches courses in Environmental Law, Law, Science and Technology, Genetics and the Law, Biotechnology, Science, Law and Policy, and Nanotechnology Law and Policy. He was named a Regents' Professor in 2011, is the Lincoln Professor of Emerging Technologies, Law and Ethics and also is a professor in ASU's School of LIfe Sciences.
Categories: In the Media, Law, Science & InnovationNumber of views: 10092